低MKRN1表达促进白血病细胞的增殖
Li Song1, Rujin Tian2, Yv Hei2,3
1Hematology-Oncology, Children's Hospital Affiliated to Shandong University, Jinan Children's Hospital, Jinan, 250022, Shandong Province, China.
European journal of medical research
|November 19, 2025
概括
MKRN1基因表达在急性淋巴细胞白血病 (ALL) 中较低,并且与预后不佳有关. 高MKRN1水平表明治疗反应更好,将其确定为ALL的潜在生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- MKRN1基因,E3泛素酶,与各种癌症有关,但其在急性淋巴细胞白血病 (ALL) 中的作用仍然未被描述.
- 了解MKRN1在ALL中的功能对于开发新的治疗策略至关重要.
研究的目的:
- 研究MKRN1基因在急性淋巴细胞白血病 (ALL) 中的表达,预后价值和功能作用.
- 确定MKRN1是否可以作为预测ALL患者治疗反应和预后的新生物标志物.
主要方法:
- 使用公共数据库和R包 limma分析MKRN1表达和ALL的预后.
- 通过在NALM6和Jurkat细胞系中通过敲击和过度表达对MKRN1在白血病细胞增殖中的作用的实验验证.
- 在儿科ALL患者中,MKRN1表达与临床特征和最小残留疾病 (MRD) 的相关性分析.
主要成果:
- 与健康对照组相比,LLA儿童的MKRN1表达显著降低,表达较低与预后较差相关.
- 过度表达MKRN1抑制了Jurkat细胞的增殖,而MKRN1的淘汰增强了NALM6细胞的增殖.
- MKRN1表达水平与风险分层,初始血细胞计数,爆破率和MRD状态有关,高MKRN1是MRD消极性的保护因素.
结论:
- MKRN1在调节白血病细胞增殖方面发挥着重要作用,其缺席促进了增殖.
- 高MKRN1表达与有利的早期治疗反应有关,并作为ALL的积极预后因素.
- 已确定MKRN1为急性淋巴细胞白血病的新型潜在生物标志物.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K


